One such biomarker is chitinase‐3‐like protein 1 (YKL‐40), a study of which has shown that the protein is elevated in the cerebrospinal fluid of RRMS patients, but this wasn't the same for PPMS or healthy subjects. Here, CHI3L1 is linked to primary progressive multiple sclerosis.